J. Dorfman

J. Dorfman, W. Burgers, D. Martin, 2015, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Prevalence of Congenital Cytomegalovirus Infection and Associated Risk of In-utero HIV Acquisition in a High HIV Prevalence Setting, South Africa.

Stephanie A. Jones, S. Madhi, J. Dorfman, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

On the role of self‐recognition in T cell responses to foreign antigen

R. Germain, J. Dorfman, M. Tsukamoto, 2003, Immunological reviews.

Molecular Basis of Unusually High Neutralization Resistance in Tier 3 HIV-1 Strain 253-11

J. Dorfman, J. Julien, J. Ereño-Orbea, 2018, Journal of Virology.

Combined HIV Adolescent Prevention Study (CHAPS): comparison of HIV pre-exposure prophylaxis regimens for adolescents in sub-Saharan Africa—study protocol for a mixed-methods study including a randomised controlled trial

J. Seeley, P. Kaleebu, S. Khoo, 2020, Trials.

Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency

J. Dorfman, M. Schomaker, F. Abrahams, 2015, Journal of Virology.

Immunogenicity of a single-dose compared with a two-dose primary series followed by a booster dose of ten-valent or 13-valent pneumococcal conjugate vaccine in South African children: an open-label, randomised, non-inferiority trial

S. Madhi, J. Dorfman, D. Goldblatt, 2020, The Lancet. Infectious diseases.

Single priming and booster dose of ten-valent and 13-valent pneumococcal conjugate vaccines and Streptococcus pneumoniae colonisation in children in South Africa: a single-centre, open-label, randomised trial

S. Madhi, J. Dorfman, C. Cutland, 2023, The Lancet. Child & adolescent health.

NK and CTL recognition of a single chain H-2Dd molecule: distinct sites of H-2Dd interact with NK and TCR.

J. Berzofsky, D. Margulies, J. Dorfman, 1999, Journal of immunology.

The basis for self-tolerance of natural killer cells in beta2-microglobulin- and TAP-1- mice.

J. Dorfman, J. Zerrahn, D. Raulet, 1997, Journal of Immunology.

The HIV-1 transmission bottleneck

J. Dorfman, P. Selhorst, K. Ariën, 2017, Retrovirology.

MHC-dependent survival of naïve T cells? A complicated answer to a simple question.

R. Germain, J. Dorfman, 2002, Microbes and infection.

Structural Rearrangements Maintain the Glycan Shield of an HIV-1 Envelope Trimer After the Loss of a Glycan

Oliver C. Grant, S. Travers, R. Woods, 2018, Scientific Reports.

In utero human cytomegalovirus infection is associated with increased levels of putatively protective maternal antibodies in nonprimary infection: evidence for boosting but not protection.

S. Madhi, J. Dorfman, P. Moore, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Dose finding study for on-demand HIV pre-exposure prophylaxis for insertive sex in sub-Saharan Africa: results from the CHAPS open label randomised controlled trial

J. Seeley, P. Kaleebu, S. Khoo, 2023, EBioMedicine.

Compartmentalization and Clonal Amplification of HIV-1 in the Male Genital Tract Characterized Using Next-Generation Sequencing.

J. Dorfman, C. Williamson, P. Selhorst, 2020 .

Compartmentalization and Clonal Amplification of HIV-1 in the Male Genital Tract Characterized Using Next-Generation Sequencing

J. Dorfman, P. Selhorst, K. Ariën, 2020, Journal of virology.

Analysis of serum microRNA‐122 in a randomized controlled trial of N‐acetylcysteine for treatment of antituberculosis drug‐induced liver injury

M. Pirmohamed, Eithne Costello, G. Maartens, 2023, British journal of clinical pharmacology.

Variability and Robustness in T Cell Activation from Regulated Heterogeneity in Protein Levels

R. Germain, G. Altan-Bonnet, O. Feinerman, 2008, Science.